Coronavirus: Tracking India's coronavirus vaccine progress

The central government plans to provide Covid vaccines to around 25 crore people out of the country total population of 130 crore by July 2021. The target is to procure between 400 and 500 million vaccine doses on equitable access basis. But are we any closer to a vaccine? Let's find out

The central government plans to provide Covid vaccines to around 25 crore people out of the country total population of 130 crore by July 2021. The target is to procure between 400 and 500 million vaccine doses on equitable access basis. But are we any closer to a vaccine? Let's find out

Vaccine 1: Covishield
Company: Serum Insititute of India
Number of volunteers: 1600
Status of trial: Phase 3 ongoing
Type of vaccine: Non-replicating viral vector (chimp adenovirus)

Vaccine 1: Covishield
Company: Serum Insititute of India
Number of volunteers: 1600
Status of trial: Phase 3 ongoing
Type of vaccine: Non-replicating viral vector (chimp adenovirus)

Vaccine 2: Sputnik V
Company: Dr Reddy's + Gamaleya Research Institute
Number of volunteers: 76
Status of trial: Permission sought for phase 3
Type of vaccine: Non-replicating viral vector (human adenovirus)

Vaccine 2: Sputnik V
Company: Dr Reddy's + Gamaleya Research Institute
Number of volunteers: 76
Status of trial: Permission sought for phase 3
Type of vaccine: Non-replicating viral vector (human adenovirus)

Vaccine 3: Covaxin
Company: Bharat Biotech
Number of volunteers: 1125
Status of trial: Phase 2 ongoing
Type of vaccine: Whole virion inactivated vaccine

Vaccine 3: Covaxin
Company: Bharat Biotech
Number of volunteers: 1125
Status of trial: Phase 2 ongoing
Type of vaccine: Whole virion inactivated vaccine

Vaccine 4: ZyCov-D
Company: Zydus Cadila
Number of volunteers: 1048
Status of trial: Phase 2 ongoing
Type of vaccine: Plasmid DNA

Vaccine 4: ZyCov-D
Company: Zydus Cadila
Number of volunteers: 1048
Status of trial: Phase 2 ongoing
Type of vaccine: Plasmid DNA

Vaccine 5: RBD Vaccine
Company: Biologicale + Baylor College of Medicine
Number of volunteers: 400
Status of trial: Permission sought for phase 3
Type of vaccine: Recombinant protein vaccine

Vaccine 5: RBD Vaccine
Company: Biologicale + Baylor College of Medicine
Number of volunteers: 400
Status of trial: Permission sought for phase 3
Type of vaccine: Recombinant protein vaccine